Affiliation:
1. Departments of Developmental Biology and Medicine (Oncology Division), Stanford University School of Medicine, Stanford, California 94305;
Abstract
Once thought incapable of significant proliferation, the pancreatic β-cell has recently been shown to harbor immense powers of self-renewal. Pancreatic β-cells, the sole source of insulin in vertebrate animals, can grow facultatively to a degree unmatched by other organs in experimental animals. β-cell growth matches changes in systemic insulin demand, which increase during common physiologic states such as aging, obesity, and pregnancy. Compensatory changes in β-cell mass are controlled by β-cell proliferation. Here we review recent advances in our understanding of the intrinsic factors and mechanisms that control β-cell cycle progression. Dysregulation of β-cell proliferation is emerging as a fundamental feature in the pathogenesis of human disease states such as cancer and diabetes mellitus. New experimental observations and studies of these diseases suggest that β-cell fate and expansion are coordinately regulated. We speculate on how these advances may accelerate the discovery of new strategies for the treatment of diseases characterized by a deficiency or excess of β-cells.
Subject
Cell Biology,Developmental Biology
Cited by
148 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献